Lisa Ye - Profile and Investment Details

Investor Profile

Lisa Ye is a Venture Capital, Private Equity Firm based in Shanghai, China with a diverse investment portfolio that includes companies such as InfiNovo, HYGEIA Healthcare Group, Phyplus, Immupeutics Medicine, OBiO Technology, Allist Pharmaceuticals, The Child AcademyChaodian Culture, Jinfuzi, China Mercy Health Group, Teligene, Abbisko Therapeutics, Gaosi Education Group, Mabwell Biotech, Linklogis, Medilink Therapeutics, Bilibili, EVE Energy, Rishiji, Pipilu, Innocare, Wajijia Entertainment, Zhaoke Ophthalmology Pharmaceutical, Juvenile Get, Sinovent, Innomed, Sugarman Media, Immune-Onc Therapeutics, Didi, ECNUAS, Studio9, CARsgen Therapeutics, Shanghai Henlius Biotech, GeneCast Biotechnology, Children's House Of Virtues, Pop Mart, Regor Therapeutics, Heyuan Biotechnology, Kaishu Jianggushi, Luogic Thinking, NetEase Cloud Music, iDreamsky Technology, Beaver Education, Shanghai Junshi Biosciences, Fortune Finance, Haixue, Arctic Vision, Xinshixiang, Remegen, Avary Holding, Mahua Fun Age, Kangning Hospital, JW Therapeutics, WeShare, Akeso Biopharma, ByteDance, Sound Solutions, . Over time, Lisa Ye has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Lisa Ye is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Life Science, Emerging Markets, Biotechnology, Genomics, Mergers and Acquisitions, Health Diagnostics, Medical, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with Lisa Ye, as their portfolio suggests a familiarity and interest in this area.

Understanding Lisa Ye’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.